IRIS
NECCHI, ANDREA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 1.552
NA - Nord America 1.235
AS - Asia 835
SA - Sud America 11
AF - Africa 9
Continente sconosciuto - Info sul continente non disponibili 8
OC - Oceania 5
Totale 3.655
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.225
SE - Svezia 896
SG - Singapore 512
RU - Federazione Russa 264
CN - Cina 246
IT - Italia 182
FI - Finlandia 67
DE - Germania 66
IN - India 50
IE - Irlanda 30
GB - Regno Unito 11
CA - Canada 9
NL - Olanda 9
EU - Europa 8
PL - Polonia 7
ES - Italia 6
HK - Hong Kong 5
AU - Australia 4
IR - Iran 4
JP - Giappone 4
NG - Nigeria 4
PE - Perù 4
CO - Colombia 3
BE - Belgio 2
BR - Brasile 2
CZ - Repubblica Ceca 2
FR - Francia 2
GR - Grecia 2
ID - Indonesia 2
IL - Israele 2
KE - Kenya 2
MY - Malesia 2
SK - Slovacchia (Repubblica Slovacca) 2
UY - Uruguay 2
VN - Vietnam 2
ZA - Sudafrica 2
AZ - Azerbaigian 1
BG - Bulgaria 1
KR - Corea 1
KZ - Kazakistan 1
LT - Lituania 1
MX - Messico 1
NZ - Nuova Zelanda 1
PK - Pakistan 1
RO - Romania 1
SA - Arabia Saudita 1
TN - Tunisia 1
TR - Turchia 1
UA - Ucraina 1
Totale 3.655
Salva come PNG Salva come JPEG
Città #
Lawrence 302
Princeton 302
Singapore 274
Moscow 178
Ashburn 148
Shanghai 113
New York 109
Helsinki 62
Boardman 58
Milan 58
Rome 33
Dublin 30
Pune 20
Hanover 10
Washington 10
Guangzhou 9
Mumbai 8
Dallas 7
Los Angeles 7
Seattle 7
Turin 7
Jiaxing 6
Kassel 6
Beijing 5
Cologne 5
Borås 4
Burari 4
Chandigarh 4
Chyliczki 4
Dresden 4
Frankfurt am Main 4
Hyderabad 4
Lappeenranta 4
Vaprio d'Adda 4
Vazzola 4
Wuxi 4
Xi'an 4
Amsterdam 3
Bilbao 3
Bogotá 3
Lucca 3
Melbourne 3
Quanzhou 3
Rozzano 3
Santa Clara 3
Shingle Springs 3
Taizhou 3
The Bronx 3
Verona 3
Zanjan 3
Arvada 2
Atlanta 2
Azzano Decimo 2
Buffalo 2
Cortona 2
Council Bluffs 2
Delhi 2
Detroit 2
Foshan 2
Genoa 2
Hanoi 2
Holyhead 2
Hong Kong 2
Jakarta 2
Jinhua 2
Kuala Lumpur 2
Lagos 2
Latina 2
Lima 2
Lissone 2
Montevideo 2
Mushin 2
Nairobi 2
Nove Sady 2
Ottawa 2
Panorama City 2
Pescara 2
Pisa 2
Placentia 2
Pretoria 2
Redwood City 2
Rockland 2
Rockville 2
San Jose 2
Shenzhen 2
Silver Spring 2
Soverato Marina 2
Toronto 2
Warsaw 2
Alkmaar 1
Alton 1
Amritsar 1
Astana 1
Athens 1
Baku 1
Bengbu 1
Berlin 1
Brussels 1
Calgary 1
Castagneto 1
Totale 1.950
Salva come PNG Salva come JPEG
Nome #
Androgen annihilation versus advanced androgen blockage as first line treatment for metastatic castration resistant prostate cancer: A systematic review and meta-analysis 34
PF-03446962, a fully-human monoclonal antibody against transforming growth-factor beta (TGF beta) receptor ALK1, in pre-treated patients with urothelial cancer: an open label, single-group, phase 2 trial 34
[18F]Fluoro-Deoxy-Glucose positron emission tomography to evaluate lymph node involvement in patients with muscle-invasive bladder cancer receiving neoadjuvant pembrolizumab 33
Impact of Molecular Subtyping and Immune Infiltration on Pathological Response and Outcome Following Neoadjuvant Pembrolizumab in Muscle-invasive Bladder Cancer 32
Chemotherapy and advanced androgen blockage, alone or combined, for metastatic hormone-sensitive prostate cancer a systematic review and meta-analysis 31
Head-to-head comparison of all the prognostic models recommended by the European Association of Urology Guidelines to predict oncologic outcomes in patients with renal cell carcinoma 31
How to optimize the use of adjuvant pembrolizumab in renal cell carcinoma: which patients benefit the most? 31
A comprehensive assessment of frailty status on surgical, functional and oncologic outcomes in patients treated with partial nephrectomy––A large, retrospective, single-center study 31
Von Hippel-Lindau disease-associated renal cell carcinoma: a call to action 30
A feasibility study of preoperative pembrolizumab before radical nephroureterectomy in patients with high-risk, upper tract urothelial carcinoma: PURE-02 29
Clinical, pathological and long-term oncologic outcomes of papillary type I vs. type II renal cell carcinoma 28
Can Negative Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Avoid the Need for Pelvic Lymph Node Dissection in Newly Diagnosed Prostate Cancer Patients? A Systematic Review and Meta-analysis with Backup Histology as Reference Standard 27
Unfavorable Cancer-specific Survival After Neoadjuvant Chemotherapy and Radical Cystectomy in Patients With Bladder Cancer and Squamous Cell Variant: A Multi-institutional Study 26
Immunotherapy versus chemotherapy as first-line treatment for advanced urothelial cancer: A systematic review and meta-analysis 25
A global approach to improving penile cancer care 25
Does the administration of preoperative pembrolizumab lead to sustained remission post-cystectomy? First survival outcomes from the PURE-01 study☆ 25
Neoadjuvant and adjuvant immunotherapy in renal cell carcinoma 25
Cabozantinib Plus Durvalumab in Patients With Advanced Urothelial Carcinoma After Platinum Chemotherapy: Safety and Preliminary Activity of the Open-Label, Single-Arm, Phase 2 ARCADIA Trial 25
Bladder-sparing combination treatments for muscle-invasive bladder cancer: A plea for standardized assessment and definition of clinical trials endpoints 25
A Plea for Economically Sustainable Evidence-based Guidelines 25
Immunotherapy in advanced kidney cancer: an alternative meta-analytic method using reconstructed survival data in case of proportional hazard assumption violation 24
A risk calculator predicting recurrence in lymph node metastatic penile cancer 24
Laparoscopic Postchemotherapy Retroperitoneal Lymph-Node Dissection Can Be a Standard Option in Defined Nonseminomatous Germ Cell Tumor Patients 23
Contemporary Treatment Patterns and Outcomes for Patients with Penile Squamous Cell Carcinoma: Identifying Management Gaps to Promote Multi-institutional Collaboration 23
Penile cancer 23
Efficacy and toxicity of antibody-drug conjugates in the treatment of metastatic urothelial cancer: A scoping review 23
Pembrolizumab in advanced renal cell carcinoma: a meta-analysis providing level 1a evidence 22
[The treatment of early-stage germ cell tumors of the testis (GCTT)]. [Il trattamento dei Tumori Germinali del Testicolo (TGT) in fase iniziale.] 22
A Combination of Cisplatin and 5-Fluorouracil With a Taxane in Patients Who Underwent Lymph Node Dissection for Nodal Metastases From Squamous Cell Carcinoma of the Penis: Treatment Outcome and Survival Analyses in Neoadjuvant and Adjuvant Settings 22
High-risk Surgically Resected Renal Cell Carcinoma: Is There a Role for Adjuvant VEGF-TKI Inhibitors? 22
Bladder cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up 21
The role of 18F-FAZA PET/CT in detecting lymph node metastases in renal cell carcinoma patients: a prospective pilot trial 21
Incidence and Clinical Impact of Inflammatory Fluorodeoxyglucose Positron Emission Tomography Uptake After Neoadjuvant Pembrolizumab in Patients with Organ-confined Bladder Cancer Undergoing Radical Cystectomy 20
Surgical Safety of Radical Cystectomy and Pelvic Lymph Node Dissection Following Neoadjuvant Pembrolizumab in Patients with Bladder Cancer: Prospective Assessment of Perioperative Outcomes from the PURE-01 Trial 20
Re: Madhuri Koti, Molly A. Ingersoll, Shilpa Gupta, et al. Sex Differences in Bladder Cancer Immunobiology and Outcomes: A Collaborative Review with Implications for Treatment. Eur Urol Oncol 2020;3:622-30 20
Intermediate- and high-risk nonmuscle invasive bladder cancer: Where do we stand? 20
Primary Renal Tumour Response to Immunotherapy: Lessons from Metastatic Disease and Insights into Earlier Settings 20
Multidisciplinary management of patients diagnosed with von Hippel-Lindau disease: A practical review of the literature for clinicians 19
A nomogram including baseline prognostic factors to estimate the activity of second-line therapy for advanced urothelial carcinoma 19
Brentuximab Vedotin in CD30-Expressing Germ Cell Tumors After Chemotherapy Failure 19
Association Between Human Papillomavirus Infection and Outcome of Perioperative Nodal Radiotherapy for Penile Carcinoma 19
Survival Outcomes After Immediate Radical Cystectomy Versus Conservative Management with Bacillus Calmette-Guérin Among T1 High-grade Micropapillary Bladder Cancer Patients: Results from a Multicentre Collaboration 19
Clinical Outcomes of Patients With Metastatic Urothelial Carcinoma After Progression to Immune Checkpoint Inhibitors: A Retrospective Analysis by the Meet-Uro Group (Meet-URO 1 Study) 19
Reliability of Serum Tumor Marker Measurement to Diagnose Recurrence in Patients with Clinical Stage I Nonseminomatous Germ Cell Tumors Undergoing Active Surveillance: A Systematic Review 19
An Open-label Randomized Phase 2 study of Durvalumab Alone or in Combination with Tremelimumab in Patients with Advanced Germ Cell Tumors (APACHE): Results from the First Planned Interim Analysis 18
Clinical Outcome in Testicular Sex Cord Stromal Tumors: Testis Sparing vs Radical Orchiectomy and Management of Advanced Disease 18
Accuracy of Transurethral Resection of the Bladder in Detecting Variant Histology of Bladder Cancer Compared with Radical Cystectomy 18
Is There a Detrimental Effect of Antibiotic Therapy in Patients with Muscle-invasive Bladder Cancer Treated with Neoadjuvant Pembrolizumab? 18
Re: Updated Results of PURE-01 with Preliminary Activity of Neoadjuvant Pembrolizumab in Patients with Muscle-Invasive Bladder Carcinoma with Variant Histologies 17
Teratoma With Somatic-Type Malignant Components in Germ Cell Tumors of the Testis: A Clinicopathologic Analysis of 40 Cases With Outcome Correlation 17
Comparative Genomic Profiling of Refractory and Metastatic Penile and Nonpenile Cutaneous Squamous Cell Carcinoma: Implications for Selection of Systemic Therapy 17
Targetable gene fusions and aberrations in genitourinary oncology 17
Can Patients with Muscle-invasive Bladder Cancer and Fibroblast Growth Factor Receptor-3 Alterations Still Be Considered for Neoadjuvant Pembrolizumab? A Comprehensive Assessment from the Updated Results of the PURE-01 Study 17
Enfortumab vedotin after PD-1 or PD-L1 inhibitors in cisplatin-ineligible patients with advanced urothelial carcinoma (EV‑201): a multicentre, single-arm, phase 2 trial 17
Molecular subtyping and immune-gene signatures identify a subset of early bladder tumors as candidates for single-agent immune-checkpoint inhibition 17
Risk factors and survival outcomes for upstaging after inguinal lymph node dissection for cN1 penile squamous cell carcinoma 16
Advanced Squamous Cell Carcinomas of the Pelvic and Perineal Region: A Comprehensive Genomic Profiling Study 16
Nomogram-based prediction of overall survival after regional lymph node dissection and the role of perioperative chemotherapy in penile squamous cell carcinoma: A retrospective multicenter study 16
An open-label, single-arm, phase 2 study of the Aurora kinase A inhibitor alisertib in patients with advanced urothelial cancer 16
Multicenter Validation of Histopathologic Tumor Regression Grade After Neoadjuvant Chemotherapy in Muscle-invasive Bladder Carcinoma 16
Pazopanib in advanced and platinum-resistant urothelial cancer: an open-label, single group, phase 2 trial 16
Prediction of the Need for an Extended Lymphadenectomy at the Time of Radical Cystectomy in Patients with Bladder Cancer 16
Neoadjuvant versus adjuvant chemotherapy for upper tract urothelial carcinoma 16
The Leydig cell tumour Scaled Score (LeSS): a method to distinguish benign from malignant cases, with additional correlation with MDM2 and CDK4 amplification 16
Second line salvage systemic therapy for advanced penile cancer 16
Should Upper-tract Urothelial Carcinoma and Bladder Carcinoma Be Treated the Same or Different? 16
Contrasting genomic profiles from metastatic sites, primary tumors, and liquid biopsies of advanced prostate cancer 16
Adjuvant Systemic Therapy for High-risk Muscle-invasive Bladder Cancer After Radical Cystectomy: Current Options and Future Opportunities 16
The obesity paradox in metastatic castration-resistant prostate cancer 16
Causal contributors to tissue stiffness and clinical relevance in urology 16
Autoantibody positivity predicts severity of rheumatic immune-related adverse events to immune-checkpoint inhibitors 15
Neglected lymph nodal metastases in patients with renal cancer: when to extend the anatomical template of lymph node dissection during nephrectomy 15
Adjuvant Therapy in Nonmetastatic High-risk Kidney Cancer: Importance of the Timing of Postnephrectomy Imaging and Treatment Delivery 15
Coming of Age of Immunotherapy of Urothelial Cancer 15
A vision of immuno-oncology: the Siena think tank of the Italian network for tumor biotherapy (NIBIT) foundation 15
Long-term functional outcomes in patients undergoing radical nephrectomy for renal cell carcinoma and tumor thrombus 14
Use of 18F-fluoro-2-deoxy-d-glucose (18F-FDG) PET/CT for lymph node assessment before radical cystectomy in bladder cancer patients 14
Prostatic metastases from testicular nonseminomatous germ cell cancer: Two case reports and a review of the literature 14
Neoadjuvant sorafenib, gemcitabine, and cisplatin administration preceding cystectomy in patients with muscle-invasive urothelial bladder carcinoma: An open-label, single-arm, single-center, phase 2 study 14
Combination of Paclitaxel, Cisplatin, and Gemcitabine (TPG) for Multiple Relapses or Platinum-Resistant Germ Cell Tumors: Long-Term Outcomes 14
Understanding the somatic-type malignant differentiation in male germ-cell cancer: A work in progress. Response to the article by Spiess et al., Malignant transformation of testicular teratoma: A chemoresistant phenotype. Urol Oncol 2008;26:595-9 14
First-line therapy with dacomitinib, an orally available pan-HER tyrosine kinase inhibitor, for locally advanced or metastatic penile squamous cell carcinoma: results of an open-label, single-arm, single-centre, phase 2 study 14
Adjuvant chemotherapy is ineffective in patients with bladder cancer and variant histology treated with radical cystectomy with curative intent 14
Evaluation of cognitive function in trials testing new-generation hormonal therapy in patients with prostate cancer: A systematic review 14
The new era of precision urobiome: RE: “Characterization of urinary microbiome in patients with bladder cancer: Results from a single-institution, feasibility study” by Chipollini et al 14
Re: Siamak Daneshmand, Azadeh Nazemi. Neoadjuvant Chemotherapy in Variant Histology Bladder Cancer: Current Evidence. Eur Urol Focus 2020;6:639–41 14
Association of Androgen Receptor Expression on Tumor Cells and PD-L1 Expression in Muscle-Invasive and Metastatic Urothelial Carcinoma: Insights for Clinical Research 14
Impact of Adjuvant Chemotherapy on Survival of Patients with Advanced Residual Disease at Radical Cystectomy following Neoadjuvant Chemotherapy: Systematic Review and Meta-Analysis 14
Upper Tract Urothelial Carcinoma in the Lynch Syndrome Tumour Spectrum: A Comprehensive Overview from the European Association of Urology - Young Academic Urologists and the Global Society of Rare Genitourinary Tumors 14
Patterns of Recurrence following Inguinal Lymph Node Dissection for Penile Cancer: Optimizing Surveillance Strategies 14
FORT-1: Phase II/III Study of Rogaratinib Versus Chemotherapy in Patients With Locally Advanced or Metastatic Urothelial Carcinoma Selected Based on FGFR1/3 mRNA Expression 13
Development of a Prediction Tool for Exclusive Locoregional Recurrence After Radical Cystectomy in Patients With Muscle-Invasive Bladder Cancer 13
Neoplasie dell'Apparato genitale maschile: Testicolo 13
Neoplasie dell'apparato genitale maschile: Carcinoma del Pene 13
A Prognostic Model Including Pre- and Postsurgical Variables to Enhance Risk Stratification of Primary Mediastinal Nonseminomatous Germ Cell Tumors: The 27-Year Experience of a Referral Center 13
Conventional-Dose Versus High-Dose Chemotherapy As First Salvage Treatment in Male Patients With Metastatic Germ Cell Tumors: Evidence From a Large International Database 13
Prognostic Effect of FGFR Mutations or Gene Fusions in Patients with Metastatic Urothelial Carcinoma Receiving First-line Platinum-based Chemotherapy: Results from a Large, Single-institution Cohort 13
Penile cancer 13
From the Uncertainties to the Evidence: A Brief History of Immunotherapy as Salvage Therapy for Advanced Bladder Cancer Through a Meta-analysis 13
Funcion sparing surgery in uro-oncology: germ cell tumors of the testis [La chirurgia "function sparing" in urologia oncologica: tumori germinali del testicolo (TGT)] 13
Totale 1.921
Salva come PNG Salva come JPEG
Categoria #
all - tutte 77.510
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 77.510
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20206 0 0 0 0 2 0 0 0 2 2 0 0
2020/2021233 0 0 0 2 169 19 39 0 4 0 0 0
2021/2022270 0 53 3 101 1 8 13 10 13 11 4 53
2022/20231.668 675 354 123 38 18 233 47 94 48 5 15 18
2023/2024934 23 57 65 63 79 182 132 118 7 20 44 144
2024/2025917 602 94 75 78 68 0 0 0 0 0 0 0
Totale 4.042